sars cov 2 variante omikron

The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2

Nature - 22 Feb 2025
The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2 ...

Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study

The Lancet - 30 Jan 2025
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study ...

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

News-Medical - 06 Feb 2025
Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence ...

A new COVID variant is on the rise. Here’s what to know about LP.8.1

The Conversation - 01 Apr 2025
A new COVID variant is on the rise. Here’s what to know about LP.8.1 ...

Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategy

ScienceDirect.com - 01 Nov 2024
Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategy ...

(PDF) Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa

ResearchGate - 10 Dec 2024
(PDF) Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa ...

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron

Nature - 05 Feb 2025
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron ...

Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant

ScienceDirect.com - 14 Dec 2024
Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant ...

Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial

The Lancet - 23 Oct 2024
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial ...

Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis

Nature - 15 Nov 2024
Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis ...

Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2

Nature - 05 Mar 2025
Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2 ...

Comparative spatial–temporal analysis of SARS-CoV-2 lineages B.1.1.33 and BQ.1.1 Omicron variant across pandemic phases

Nature - 25 Mar 2025
Comparative spatial–temporal analysis of SARS-CoV-2 lineages B.1.1.33 and BQ.1.1 Omicron variant across pandemic phases ...

Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections

Nature - 09 Jan 2025
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections ...

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology

Nature - 11 Jan 2025
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology ...

Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses | npj Viruses

Nature - 21 Nov 2024
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses | npj Viruses ...